Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Clin Exp Dermatol ; 42(7): 728-734, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28649780

RESUMEN

BACKGROUND: Tranexamic acid (TXA) has been used orally, intravenously, topically and intradermally (microinjection, microneedling) for treating melasma. However, the comparative efficacy of these different routes of administration remains underevaluated. AIM: To ascertain the comparative efficacy of different routes of administration of TXA. METHODS: In total, 100 consecutive patients with melasma (8 men, 92 women, age range 18-55 years) were randomly assigned to one of two groups comprising 50 patients each. Group A (3 men, 47 women) received oral TXA 250 mg twice daily, while group B (5 men, 45 women) received intradermal microinjections of TXA 4 mg/mL every 4 weeks. The treatment continued for 12 weeks in both groups. Percentage reduction in baseline Melasma Area and Severity Index (MASI) was assessed at 4-week intervals, and response was scored as very good (> 75% reduction), good (50% to < 75% reduction), moderate (25% to < 50% reduction), mild (< 25% reduction) or no response. RESULTS: The study was completed by 39 patients in group A and 41 patients in group B. Very good response was seen in 25 and 32 patients in groups A and B, respectively, while good response was seen in 14 and 9 patients, respectively. Both treatment methods were equally effective, with an average reduction of MASI at 12 weeks of 77.96 ± 9.39 in group A and 79.00 ± 9.64 in group B. The main adverse effects were mild epigastric discomfort, hypomenorrhea, headache and injection site pain, which did not warrant discontinuation of treatment. Two patients in group A had relapses at 24 weeks. CONCLUSION: TXA appears to be an effective and safe treatment for melasma, irrespective of its route of administration.


Asunto(s)
Melanosis/tratamiento farmacológico , Ácido Tranexámico/administración & dosificación , Administración Oral , Adolescente , Adulto , Femenino , Humanos , Inyecciones Intradérmicas/efectos adversos , Masculino , Microinyecciones , Persona de Mediana Edad , Ácido Tranexámico/efectos adversos , Adulto Joven
2.
Indian J Lepr ; 88(1): 13-19, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29741821

RESUMEN

The rheumatological manifestations of leprosy occur singly or in varying combinations, particularly during lepra reactions. Despite being third most common, these remain under diagnosed and under reported. This study has been carried out to study the spectrum of rheumatological manifestations in leprosy patients. One hundred consecutive patients of leprosy presenting during January to December 2013 were studied for rheumatological manifestations. Complete hemogram, serum biochemistry, urinalysis, rheumatoid factor, ASO titer, C-reactive protein, ANA, and x-rays for hands, feet, chest and involved joints were performed. These 100 (M:F 66:34) patients aged between 16-80 years had indeterminate (2 patients), TT (4 patients), BT (26 patients), BB (2 patients), and LL leprosy (32 patients). 27 patients had rheumatological manifestations; arthritis involving large or small joints in 23 patients being the commonest. 7 of 24 patients in type-1 lepra reaction had enthesitis in 3 patients and oligoarthritis in 4 patients. Rheumatoid arthritis-like polyarthritis was noted in 19 patients with type-2 reaction. Tenosynovitis, dactylitis, bony changes were also noted. Except for one case, these features were present in patients having lepra reactions. Rheumatoid factor in 14, ANA in 15, C-reactive protein in 45 cases was positive. ASO was positive 34 cases. Symmetrical polyarthritis involving small joints of hands and feet, oligoarthritis, enthesitis and dactylitis are common in leprosy particularly with borderline leprosy, type-2 lepra reaction especially in the presence of positive RAfactor.


Asunto(s)
Lepra/complicaciones , Enfermedades Reumáticas/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Proteína C-Reactiva/metabolismo , Femenino , Humanos , India , Lepra/sangre , Masculino , Persona de Mediana Edad , Enfermedades Reumáticas/sangre , Factor Reumatoide/sangre , Reumatología , Centros de Atención Terciaria , Adulto Joven
4.
J Assoc Physicians India ; 49: 475-6, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11762623

RESUMEN

We report a case of end stage renal disease in association with bilateral renal angiomyolipomas (RAML). There were no features suggestive of tubercous sclerosis (TS). Renal angiomyolipomas were detected incidentally, patient being asymptomatic for the same. She is being evaluated for live related kidney transplant.


Asunto(s)
Angiolipoma/complicaciones , Angiolipoma/diagnóstico , Fallo Renal Crónico/complicaciones , Neoplasias Renales/complicaciones , Neoplasias Renales/diagnóstico , Adulto , Angiografía , Angiolipoma/patología , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Humanos , Fallo Renal Crónico/diagnóstico , Neoplasias Renales/patología , Tomografía Computarizada por Rayos X , Esclerosis Tuberosa/diagnóstico
5.
J Assoc Physicians India ; 49: 1197-9, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11996445

RESUMEN

For renal transplantation, an elderly cadaver donor is often rejected because of the relatively poor long-term graft survival. Considering that a number of potential recipients are waiting for a renal transplant, dual kidney transplantation would be a more appropriate approach in this situation. We report one such case with a successful outcome.


Asunto(s)
Muerte Encefálica , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Donantes de Tejidos , Adulto , Factores de Edad , Anciano , Femenino , Humanos , Masculino
6.
J Obstet Gynaecol India ; 20(4): 558-60, 1970 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12304745

RESUMEN

PIP: Between 1959 and 1968 in New Delhi, 20 patients with peritonitis or prolapse of the intestines into the vagina after attempted abortion were seen. Only one of these was performed in the Department of Obstetrics. Admission was 1-3 days after the abortion was induced. The mortality rate was 25%, with 4 of the 5 patients dying of peritonitis. The mortality was greatest in the 3 cases of large bowel injury. Details of the clinical treatment are presented.^ieng


Asunto(s)
Aborto Inducido , Estudios Retrospectivos , Perforación Uterina , Enfermedad , Servicios de Planificación Familiar , Infecciones , Investigación
7.
J Postgrad Med ; 47(1): 24-6, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11590286

RESUMEN

BACKGROUND: We have noticed a recent rise in the incidence and severity of acute renal failure (ARF) in malaria. AIM: To study the incidence, severity and outcome of ARF in malaria. SETTING AND DESIGN: It is a retrospective analysis of data of one year from a tertiary medical centre in a metropolitan city. MATERIALS AND METHODS: Patients with ARF and smear positive malaria were evaluated. STATISTICAL ANALYSIS: Results were expressed as mean, range and standard deviation. RESULTS: Out of 402 detected smear positive malaria, 24 had ARF. Eighteen were of the age group 21-40 years. Plasmodium falciparum (PF) was detected in 16, Plasmodium vivax in three, and mixed infection in five. Non-oliguric ARF was seen in 14. Eighteen showed severe ARF (Serum creatinine >5 mg%). Twenty-two patients needed dialysis. Prolonged ARF lasting for 2-6 weeks was seen in eight. Seventeen patients recovered completely, while seven showed fatal combination of disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), severe ARF and PF malaria. No response was seen to chloroquine and artesunate given alone and twenty patients required quinine. CONCLUSION: ARF necessitating dialysis was seen in 92% of patients with ARF in malaria. PF infection, severe ARF, DIC and ARDS were poor prognostic factors. Resistance was noted to both chloroquine and artesunate.


Asunto(s)
Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/parasitología , Malaria/complicaciones , Malaria/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Animales , Antimaláricos/uso terapéutico , Resistencia a Múltiples Medicamentos , Humanos , Incidencia , India/epidemiología , Malaria/tratamiento farmacológico , Malaria/epidemiología , Malaria Falciparum/complicaciones , Malaria Falciparum/diagnóstico , Malaria Vivax/complicaciones , Malaria Vivax/diagnóstico , Persona de Mediana Edad , Plasmodium falciparum/aislamiento & purificación , Plasmodium vivax/aislamiento & purificación , Quinina/uso terapéutico , Estudios Retrospectivos
8.
Indian J Pathol Bacteriol ; 11(4): 257-60, 1968 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-5736721
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA